Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02184026 · ClinicalTrials.gov registry record · NA
Exposure, Relaxation, & Rescripting Therapy-Child
A NA study, sponsored by University of Montana.
- Completed
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT02184026: Completed NA study, sponsored by University of Montana.
NCT02184026 is a NA study that has completed, run by University of Montana. The registered enrollment target is 2 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02184026, a NA study, has completed, sponsored by University of Montana.
- COMPLETED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
The study implements a trauma-related nightmare treatment for children aged 8 to 13 years. Relevant outcome progress and outcome measures on symptoms, nightmare distress and duration, academic indicators, and sleep quality will be examined.
Primary Outcome
The TRNS-C is a 14-item self-report measure that assesses current sleep quality, frequency, severity, and duration of nightmares, as well as cognitions, emotions, and behaviors related to nightmares in children.
Interventions
- BEHAVIORAL Exposure, Relaxation, & Rescripting Therapy-Child
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2012-12 |
| Est. Completion | 2015-04 |
| Phase | NA |
What the finished NCT02184026 record still lists
NCT02184026 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Exposure, Relaxation, & Rescripting Therapy-Child is the first listed.
NCT02184026 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02184026 about?
NCT02184026 is a clinical study titled "Exposure, Relaxation, & Rescripting Therapy-Child". The study implements a trauma-related nightmare treatment for children aged 8 to 13 years. Relevant outcome progress and outcome measures on symptoms, nightmare distress and duration, academic indicators, and sleep quality will be examined.
What is the current status of trial NCT02184026?
This trial is currently completed. It is a NA study. The enrollment target is 2 participants. The study started on 2012-12. Estimated completion is 2015-04.
What interventions are being tested in trial NCT02184026?
The interventions under investigation include: Exposure, Relaxation, & Rescripting Therapy-Child (BEHAVIORAL).
Who is sponsoring clinical trial NCT02184026?
This trial is sponsored by University of Montana, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02184026's enrollment target sits among peer trials
2 1997th of 2000 the lowest of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia